Abstract
The research group works in the following fields: development of epigenetic and non-epigenetic modulators for the treatment of hematologic tumors. design and synthesis of inhibitors targeting enzymes of the endocannabinoid system for the development of therapeutic agents for neurodegenerative diseases and epilepsy treatment. synthesis of new pharmacological tools for the treatment of rare diseases. Design and synthesis of enzymatic inhibitors or receptor modulators for the
development of new infectious agents. Green chemistry methods for the development of new neurodegeneration modulators.
Tag:
Area:
Research Institution:
Università degli Studi di Siena
Technologies, Systems, Applications:
Food production, preservation and traceability, New drugs development
Technological Priority:
Biomedical, pharmaceutical, pharmacological technologies, Nutraceuticals